Skip to main content
. Author manuscript; available in PMC: 2022 Apr 15.
Published in final edited form as: J Neurol Sci. 2021 Feb 23;423:117358. doi: 10.1016/j.jns.2021.117358

Table 1.

Demographics and clinical characteristics at baseline of the patients analyzed.*

Total (n = 29) Responders (n = 18) Non-responders (n = 4)
Age 55 (10.97) 53.65 (11.68) 55.16 (9.35)
Gender
 Males 18 10 2
 Females 11 8 2
Disease duration (days) 325 (230) 302.4 (219) 281 (207)
Weight (SD) 80.25 (16.99) 76.95 (18.9) 89.55 (13.12)
ALSFRS-R total score 39.51 (5.31) 40.06 (5.12) 40.00 (8.7)
% Predicted FVC 80.46 (16.00) 76.50 (24.37) 80.50 (14.31)
NPI 1.69 (1.49) 2.05 (1.58) 0.87 (0.45)
*

None of the parameters were statistically different between Responders and Non-responders (P > 0.5).